Catalysts for Astellas Pharma Inc
43 tracked
Feb 27, 2026
approval
IZERVAY (AVACINCAPTAD PEGOL SODIUM) — FDA approval
avacincaptad pegol sodium
→
Dec 11, 2025
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Dec 11, 2025
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Nov 21, 2025
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Mar 21, 2025
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Mar 21, 2025
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Feb 27, 2025
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Feb 12, 2025
approval
IZERVAY (AVACINCAPTAD PEGOL SODIUM) — FDA approval
avacincaptad pegol sodium
→
Jan 22, 2025
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Jan 22, 2025
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Dec 15, 2023
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Dec 15, 2023
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Nov 16, 2023
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Nov 16, 2023
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Aug 4, 2023
approval
IZERVAY (AVACINCAPTAD PEGOL SODIUM) — FDA approval
avacincaptad pegol sodium
→
Apr 18, 2023
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Apr 3, 2023
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Apr 3, 2023
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Oct 28, 2022
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Sep 9, 2022
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Sep 9, 2022
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Jan 13, 2022
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Jan 13, 2022
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Jul 9, 2021
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Jul 9, 2021
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
May 24, 2021
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Mar 22, 2021
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→
Oct 23, 2020
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Aug 4, 2020
approval
XTANDI (ENZALUTAMIDE) — FDA approval
enzalutamide
→
Dec 18, 2019
approval
PADCEV (ENFORTUMAB VEDOTIN-EJFV) — FDA approval
enfortumab vedotin
→